Gastric Inhibitory Polypeptide
"Gastric Inhibitory Polypeptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gastrointestinal peptide hormone of about 43-amino acids. It is found to be a potent stimulator of INSULIN secretion and a relatively poor inhibitor of GASTRIC ACID secretion.
| Descriptor ID |
D005749
|
| MeSH Number(s) |
D06.472.317.400 D06.472.699.275 D12.644.400.300 D12.644.548.275 D12.776.631.650.300
|
| Concept/Terms |
Gastric Inhibitory Polypeptide- Gastric Inhibitory Polypeptide
- Inhibitory Polypeptide, Gastric
- Polypeptide, Gastric Inhibitory
- Glucose-Dependent Insulin-Releasing Peptide
- Glucose Dependent Insulin Releasing Peptide
- Insulin-Releasing Peptide, Glucose-Dependent
- Peptide, Glucose-Dependent Insulin-Releasing
- Glucose Dependent Insulinotropic Peptide
- Glucose-Dependent Insulinotropic Peptide
- Insulinotropic Peptide, Glucose-Dependent
- Peptide, Glucose-Dependent Insulinotropic
- Gastric-Inhibitory Polypeptide
- Polypeptide, Gastric-Inhibitory
|
Below are MeSH descriptors whose meaning is more general than "Gastric Inhibitory Polypeptide".
Below are MeSH descriptors whose meaning is more specific than "Gastric Inhibitory Polypeptide".
This graph shows the total number of publications written about "Gastric Inhibitory Polypeptide" by people in this website by year, and whether "Gastric Inhibitory Polypeptide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastric Inhibitory Polypeptide" by people in Profiles.
-
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies. Diabetes Obes Metab. 2023 04; 25(4):965-974.
-
Efficacy of tirzepatide 5, 10 and 15?mg versus semaglutide 2?mg in patients with type 2 diabetes: An adjusted indirect treatment comparison. Diabetes Obes Metab. 2022 09; 24(9):1861-1868.
-
Incretins, Pregnancy, and Gestational Diabetes. Curr Pharm Biotechnol. 2016; 17(7):597-602.
-
Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012 Aug 30; 488(7413):621-6.
-
Entero-insular axis and postprandial insulin differences in African American and European American children. Am J Clin Nutr. 2008 Nov; 88(5):1277-83.
-
Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res. 2008 Apr; 23(4):536-43.